Edition:
International

Biotechnology & Medical Research

Moderna Says EMA CHMP Adopts Opinion Recommending Authorization For Use Of Co's COVID-19 Vaccine In Adolescents

July 23 (Reuters) - Moderna Inc ::EMA COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) ADOPTS POSITIVE OPINION RECOMMENDING AUTHORIZATION FOR THE USE OF THE MODERNA COVID-19 VACCINE IN ADOLESCENTS (12-17 YEARS OF AGE) IN THE EUROPEAN UNION.MODERNA INC - CONDUCTING A PHASE 2/3 STUDY, CALLED...

Friday, 23 Jul 2021 09:06am EDT

Moderna's COVID-19 Vaccine Approved For Children Aged 12 To 17 In EU - EMA

July 23 (Reuters) - European Medicines Agency::EMA: COVID-19 VACCINE SPIKEVAX APPROVED FOR CHILDREN AGED 12 TO 17 IN EU: 23/07/2021.EMA SAYS THE USE OF THE SPIKEVAX VACCINE IN CHILDREN FROM 12 TO 17 YEARS OF AGE WILL BE THE SAME AS IN PEOPLE AGED 18 AND ABOVE.EMA SAYS MOST COMMON SIDE EFFECTS IN...

Friday, 23 Jul 2021 08:29am EDT

Abivax: New Financing Totaling 85 Million Euros

July 23 (Reuters) - Abivax SA ::ABIVAX ANNOUNCES THE PRICING OF ITS OVERSUBSCRIBED CAPITAL INCREASE OF EUR 60M AND CONVERTIBLE BONDS OF EUR 25M, TOTALING EUR 85M NEW FINANCING.EUR 60M RESERVED PRIMARY EQUITY OFFERING AT MINIMUM DISCOUNT (3%).EUR 25M CONVERTIBLE BONDS PRICED AT 6.00% COUPON AND 25%...

Friday, 23 Jul 2021 02:00am EDT

Geneuro Reports End-Q2 Net Cash Position Of 9.2 Million Euros

July 23 (Reuters) - Geneuro SA ::GENEURO: FINANCIAL INFORMATION AND BUSINESS UPDATE FOR THE SECOND QUARTER 2021.OPERATIONS FUNDED UNTIL END-2022.END-Q2 NET CASH POSITION OF EUR 9.2 MILLION, PRO FORMA REFLECTING CAPITAL INCREASE COMPLETED IN EARLY JULY 2021.CASH CONSUMPTION RELATED TO GENEURO'S...

Friday, 23 Jul 2021 02:00am EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.